HCID 131732106, compound → HCID 88948357, compound
Reaction equation
[CH:1]([N:3]([CH2:12][C@@H:13]([CH2:40][CH2:41][CH2:42][CH3:43])[C:14]([N:16]1[C@H:20]([C:21]([NH:23][C:24]2[CH:29]=[CH:28][N:27]=[CH:26][N:25]=2)=[O:22])[CH2:19][CH2:18][N:17]1C(OCC1C=CC=CC=1)=O)=[O:15])[O:4]CC1C=CC=CC=1)=[O:2]>C(O)C.[OH-].[OH-].[Pd+2]>[CH:1]([N:3]([CH2:12][C@@H:13]([CH2:40][CH2:41][CH2:42][CH3:43])[C:14]([N:16]1[C@H:20]([C:21]([NH:23][C:24]2[CH:29]=[CH:28][N:27]=[CH:26][N:25]=2)=[O:22])[CH2:19][CH2:18][NH:17]1)=[O:15])[OH:4])=[O:2]Participants
4
Reactant 1
Product 1
Reagents, catalysts & solvents 2
Procedure
To a solution of phenylmethyl (3S)-2-[(2R)-2-({formyl[(phenylmethyl)oxy]amino}methyl)hexanoyl]-3-[(4-pyrimidinylamino)carbonyl]-1-pyrazolidinecarboxylate (80 mg, 0.136 mmol) in ethanol (30 mL) was added Pd(OH)2/C (40 mg). The mixture was stirred under an H2 atmosphere for 1 h and the catalyst was filtered off. The filtrate was concentrated and the residue was purified by pre-HPLC to provide the title compound (40 mg, 70%). LCMS: (M+H)+: 365.2.
Workup
- filtrationthe catalyst was filtered off
- concentrationThe filtrate was concentrated
- customthe residue was purified by pre-HPLC
Sources & evidence
- ORD record
- ord-f0428c131e884be48b3c7315510bc131
- Source dataset
- uspto-grants-2014_12
- Patent number
- US08901119B2
Reaction notes
Loading…